Skip to content
TaiRx, Inc. | New Drug Development Logo TaiRx, Inc. | New Drug Development Logo TaiRx, Inc. | New Drug Development Logo
  • About Us
    • Meet TaiRx
    • Vision
    • Innovation
    • Management Team
    • Scientific Advisory Committee
    • Board of Directors
  • Product Pipeline
    • CVM-1118
    • Rexis®
    • TRX-711
    • TRX-NOC
    • TRX-920
    • TRX-105
  • Market Product
  • News
  • Contact Us
  • enEnglish
    • zh-hant繁體中文
News jeff 2018-05-31T11:46:02+00:00

News

TaiRx held a pre-IPO institutional investors’ conference and announced the listing on Taiwan Emerging Market on the 20th of June.

2017/6/15 TaiRx shows its [...]

Chang Lisa 2018-06-04T17:50:50+00:00 June 15th, 2017|News|
Read More

TaiRx presents CVM-1118 Phase I Clinical Trial Progress at ASCO

2017/6/5 TaiRx, Inc. (6580) [...]

Chang Lisa 2018-06-04T17:50:56+00:00 June 5th, 2017|News|
Read More

Science reported TaiRx’s CVM-1118 as the first drug entering clinical trial, inhibiting the formation of vasculogenic mimicry in cancer.

2016/06/17 This issue of [...]

Chang Lisa 2018-06-04T17:51:02+00:00 June 18th, 2016|News|
Read More

TaiRx’s oral cancer drug with a promising forecast.

2016/3/28 […]

Chang Lisa 2021-02-17T15:02:16+00:00 March 28th, 2016|News|
Read More

23 major pharmaceutical companies attended the cross-strait new drug discussion panel.

2016/3/18 […]

Chang Lisa 2021-02-17T14:59:11+00:00 March 18th, 2016|News|
Read More
Previous234Next
Copyright© 2018 台睿生物科技股份有限公司 | 網頁設計公司:振作國際